Photo-activated protein delivery toward synergistic cancer therapy

来源 :Fourth Symposium on Innovative Polymers for Controlled Deliv | 被引量 : 0次 | 上传用户:xiaohengjun
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  RNase A is one of clinical therapeutic proteins due to its RNA cleavage capacity[1].However,the lack of tissue specificity greatly hurdles its wide utilities.Compared to normal tissue and cells,many tumor cells have greatly higher levels of reactive oxygen species (ROS).
其他文献
Inorganic nanoparticles can be coated with polymers to render them compatible with biological environment.The coating may warrant for colloidal stability,as it may be used for attaching ligands with t
We present a cationic polymer architecture composed of phenylboronic acid (PBA),sugar-installed polyethylenimine (PEI),and polyethyleneglycol (PEG) for the stimuli-responsive gene delivery.The chemica
Stem cells have been widely used in cell therapy[1].However,the low cell retention ratio and inefficient engraftment limited the efficiency of stem cell therapy[2].Injectable hydrogels with conductivi
To diagnosis and treat complicated malignant tumors effectively,multifunctional nanomedicines with targeting,imaging and controlled-releasing abilities have been exploited in the last decades.
White adipose tissue (WAT) as an anti-obesity drug target has brought much-needed attention due to the recent discoveries of several obesity-linked genes and their pathophysiological functions.WAT-tar
Gene therapy presents a unique opportunity for the treatment of genetic diseases,but the lack of multifunctional delivery systems has hindered its clinical applications.For low cytotoxicity and cargo
会议
In this talk,I will present a method for in vivo construction of supramolecular biomaterials for biomedical applications.The advantages of our system include:i) structure-controllable preparation of s
The clinical treatment efficacies of nanomedicines are commly burdened with two main challenges of inefficient tumor tissue penetration and cellular uptake owing to their poor tissue and biomembrane p
Successful accumulation of drugs specifically at diseased sites is mainly limited by biological barriers to drug transport,especially the nonspecific uptake of drug carriers in mononuclear phagocyte s